Strong Investment Pick: We at Jainam Wealth recommend to our investors to Buy Natco Pharma Ltd. (BSE : 524816) on every dips from CMP of Rs.628 for Target of Rs.950, in the coming 3 years. The company having a strong presence in oncology & gastro hepatology with diverse portfolio of 28 products. Company has filed 38 ANDAs from which still 21 ANDAs pending which is worth of around Rs. 103388 crore. Company having strong partnership with Mylan, Alvogen, Dr.reddy’s, Breckenridge Pharma, Lupin and Actavis and also having robust financial such as zero debt status, RoCE (%) of 17.87% in FY16 and PATM (%) of 13.04% in FY16.
blog comments powered by Disqus